Sax Wealth Advisors LLC lifted its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 432.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,764 shares of the company’s stock after purchasing an additional 18,485 shares during the quarter. Sax Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $2,069,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the stock. Somerset Trust Co grew its position in Colgate-Palmolive by 3.6% in the fourth quarter. Somerset Trust Co now owns 24,859 shares of the company’s stock worth $2,260,000 after acquiring an additional 863 shares in the last quarter. Merit Financial Group LLC lifted its stake in Colgate-Palmolive by 36.0% during the fourth quarter. Merit Financial Group LLC now owns 30,640 shares of the company’s stock worth $2,786,000 after purchasing an additional 8,114 shares during the last quarter. Chemistry Wealth Management LLC increased its position in shares of Colgate-Palmolive by 38.5% during the 4th quarter. Chemistry Wealth Management LLC now owns 2,926 shares of the company’s stock valued at $266,000 after purchasing an additional 814 shares during the last quarter. Boston Common Asset Management LLC raised its holdings in shares of Colgate-Palmolive by 53.1% during the 4th quarter. Boston Common Asset Management LLC now owns 268,448 shares of the company’s stock valued at $24,405,000 after buying an additional 93,121 shares in the last quarter. Finally, Relyea Zuckerberg Hanson LLC lifted its position in Colgate-Palmolive by 7.6% in the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 4,021 shares of the company’s stock worth $366,000 after buying an additional 283 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Insider Activity at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.37% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
Shares of CL opened at $88.79 on Friday. The company has a 50-day simple moving average of $92.27 and a two-hundred day simple moving average of $97.78. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market capitalization of $72.55 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Find and Profitably Trade Stocks at 52-Week Lows
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Energy and Oil Stocks Explained
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to Calculate Inflation Rate
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.